AAP Endorses New Algorithm for Critical Congenital Heart Disease Screening

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 16, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 16, 2024 -- In a clinical report published online Dec. 16 in Pediatrics, the American Academy of Pediatrics endorses a new algorithm for use in critical congenital heart disease (CCHD) screening, which was added to the U.S. Recommended Uniform Screening Panel in 2011.

Matthew E. Oster, M.D., M.P.H., from Emory University School of Medicine in Atlanta, and colleagues present updated recommendations for CCHD screening since the 2011 AAP endorsement.

The authors note that a new AAP algorithm has been endorsed for use in CCHD screening. This new algorithm has a passing oxygen saturation threshold of ≥95 percent in pre- and post-ductal measurements and has only one retest for infants who do not pass the first screen, instead of two. To aid in surveillance and monitoring of the program and continue to improve screening, state newborn screening programs should collect a recommended minimum uniform dataset. Education on the limitations of screening, the significance of non-CCHD conditions, and the importance of adhering to protocol should be provided to stakeholders. Improving overall sensitivity and implementing methods to reduce health inequities are included as future directions of CCHD screening.

"The recommended changes to the algorithm simplify the screening process, potentially decreasing error rates in the interpretation of the algorithm and reducing the time to conduct a screening," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords